Page last updated: 2024-10-15

mocimycin

Description

mocimycin: induces GTPase activity of EF-TU; N-demethyl analog of antibiotic X-5108; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135484176
CHEBI ID190786
SCHEMBL ID195770
MeSH IDM0052474

Synonyms (34)

Synonym
delvomycin
mocimycin
kirromycin
myc 8003
nsc-316094
50935-71-2
einecs 256-859-9
antibiotic myc 8003
nsc 316094
mocimycine [inn-french]
antibiotic obtained from cultures of streptomyces ramocissimus or the same substance obtained by any other means
mocimycin (trivial name)
mocimicina [inn-spanish]
mocimycinum [inn-latin]
myc-8003
(2s)-n-[(2e,4e,6s,7r)-7-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(1e,3e,5e)-7-(2-hydroxy-4-oxo-1h-pyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]-2-[(2r,3r,4r,6s)-2,3,4-trihydroxy-5,5-dimethyl-6-[(1e,3z)-penta-1,3-di
CHEBI:190786
(2s)-n-[(2e,4e,6s,7r)-7-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(1e,3e,5e)-7-(4-hydroxy-2-oxo-1h-pyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]-2-[(2r,3r,4r,6s)-2,3,4-trihydroxy-5,5-dimethyl-6-[(1e,3z)-penta-1,3-di
unii-po3aa461hs
mocimycine
mocimicina
po3aa461hs ,
mocimycinum
mocimycin [inn]
kirromycin from streptomyces collinus
mocimycin [mi]
mocimycin [mart.]
SCHEMBL195770
mocimycin; delvomycin; myc-8003
(2s)-n-[(2e,4e,6s,7r)-7-{(2s,3s,4r,5r)-3,4-dihydroxy-5-[(1e,3e,5e)-7-(4-hydroxy-2-oxo-1,2-dihydropyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trien-1-yl]tetrahydrofuran-2-yl}-6-methoxy-5-methylocta-2,4-dien-1-yl]-2-{(2r,3r,4r,6s)-2,3,4-trihydroxy-5,5-dimethyl-
HY-122386
CS-0084957
Q27286661
DTXSID201023647
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
C-glycosyl compoundA glycosyl compound arising formally from the elimination of water from a glycosidic hydroxy group and an H atom bound to a carbon atom, thus creating a C-C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (151)

TimeframeStudies, This Drug (%)All Drugs %
pre-199058 (38.41)18.7374
1990's56 (37.09)18.2507
2000's20 (13.25)29.6817
2010's17 (11.26)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (3.31%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other146 (96.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]